Margaret G. McGlynn, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 12,500 shares at $117.14 ($1.5M) on 2015-04-06, disclosed to the SEC on 2015-04-08.
Scheduled sale ($1.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $117.14 | 2,200 | $258K | 17.4% |
| 2 | $118.32 | 6,000 | $710K | 48.0% |
| 3 | $118.97 | 3,900 | $464K | 31.4% |
| 4 | $119.78 | 400 | $48K | 3.2% |
| Total | $118.36 avg | 12,500 | $1.5M | 100% |
| Filing → |
| FOLD | SELL | 2022-05-04 | $105K | — | Filing → |
| VRTX | SELL | 2022-04-12 | $1.4M | — | Filing → |
| VRTX | SELL | 2022-04-04 | $2.6M | — | Filing → |